Thymosin β15 is a positive regulator of cell motility that may prove useful as a marker of metastatic potential in prostate cancer (pages 1322–1328).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Partin, A.W., Shoeniger, J.S., Mohler, J.L. & Coffey, D.S. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc. Natl. Acad. Sci. USA 86, 1254–1258 (1989).
Bao, L. et al. Thymosin β15: A novel regulator of cell tumor motility upregulated in metastatic prostate cancer. Nature Med. 2, 1322–1328 (1996).
Stossel, T.P. On the crawling of animal cells. Science 260, 1086–1094 (1993).
Morton, R.A., Ewing, C.M., Nagafuchi, A., Tsukiata, S. & Isaacs, W.B. Reduction of Ecadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res. 53, 3585–3590 (1993).
Umbas, R. et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancers. Cancer Res. 52, 5104–5109 (1992).
Ben-Ze'ev, A., Fernandez, J.L.R., Geiger, B., Zoller, M. & Gluck, U. Cytoskeletal plaque proteins as regulators of cell motility and tumor suppressors. in Cell Mechanics and Cellular Engineering (eds. Mow, V.C., Guilak, F., Tran-Son-Tay, R. & Hochmuth, R.M.) 273–293 (Springer-Verlag, New York, 1994).
Liotta, L.A. Cancer cell invasion and metastasis. Sci. Am. 266(Feb.) 54–63 (1992).
Liotta, L.A. et al. Tumor cell autocrine motility factor. Proc.Natl.Acad.Sci.USA 83, 3302–3306 (1986).
Dong, J.-T. et al. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884–888 (1995).
Mohler, J.L. et al. Detection of candidates for cancer cell motility inhibitor protein in the Dunning adenocarcinoma model. Clin.Exp.Metastasis 13, 774–780 (1995).
Dong, J-T. et al. Down-regulation of the KAI-1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56, 4387–4390 (1996).
Pienta, K.J. & Coffey, D.S. Cell motility as a chemotherapeutic target. Cancer Surv. 11, 255–263 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coffey, D. Prostate cancer metastasis: Talking the walk. Nat Med 2, 1305–1306 (1996). https://doi.org/10.1038/nm1296-1305
Issue Date:
DOI: https://doi.org/10.1038/nm1296-1305
This article is cited by
-
Screening for motility-associated genes in malignant astrocytoma cell lines
Journal of Neuro-Oncology (2007)